Interleukin-22 receptor is a type II cytokine receptor. It binds to Interleukin-22. It is a heterodimer of α1[1] and IL-10Rβ2[1] subunits.
References
External links
|
|---|
| IL-1 |
- Antagonists: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
- Antibodies: Canakinumab
- Gevokizumab
- Lutikizumab
- Decoy receptors: Rilonacept (IL-1 Trap)
|
|---|
| IL-2 |
- Agonists: Adargileukin alfa
- Aldesleukin
- Celmoleukin
- Denileukin diftitox
- Interleukin 2
- Pegaldesleukin
- Teceleukin
- Tucotuzumab celmoleukin
- Antibodies: Basiliximab
- Daclizumab (dacliximab)
- Inolimomab
|
|---|
| IL-3 | |
|---|
| IL-4 |
- Antibodies: Dupilumab
- Pascolizumab
|
|---|
| IL-5 |
- Antibodies: Benralizumab
- Mepolizumab
- Reslizumab
- Antisense oligonucleotides: TPI ASM8
|
|---|
| IL-6 |
- Antibodies: ARGX-109
- Clazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuximab
- Sirukumab
- Tocilizumab
- Levilimab
|
|---|
| IL-7 | |
|---|
| IL-8 |
- See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.
|
|---|
| IL-9 | |
|---|
| IL-10 | |
|---|
| IL-11 | |
|---|
| IL-12 |
- Antibodies: Briakinumab
- Ustekinumab
|
|---|
| IL-13 |
- Antibodies: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
|---|
| IL-15 | |
|---|
| IL-17 |
- Antibodies: Brodalumab
- Ixekizumab
- Perakizumab
- Remtolumab
- Secukinumab
- Vunakizumab
|
|---|
| IL-18 | |
|---|
| IL-20 |
- Antibodies: Fletikumab (against IL-20)
|
|---|
| IL-21 |
- Antibodies: NNC0114-0005
- NNC0114-0006
|
|---|
|
- Antibodies: Fezakinumab (against IL-22)
|
|---|
| IL-23 |
- Agonists: Interleukin 23 (SGRF)
- Antibodies: Brazikumab
- Briakinumab
- Guselkumab
- Risankizumab
- Tildrakizumab
- Ustekinumab
|
|---|
| IL-27 | |
|---|
| IL-28 | |
|---|
| IL-31 | |
|---|
| IL1RL1 | |
|---|
| IL1RL2 | |
|---|
| Others | | JAK | |
|---|
| Others |
- Unsorted: Efavaleukin alfa
- Efineptakin alfa
|
|---|
|
|---|